Page last updated: 2024-08-21

quinazolines and Persistent Fetal Circulation Syndrome

quinazolines has been researched along with Persistent Fetal Circulation Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dukarm, RC; Morin, FC; Perry, BJ; Russell, JA; Steinhorn, RH	1

Other Studies

1 other study(ies) available for quinazolines and Persistent Fetal Circulation Syndrome

Article	Year
The cGMP-specific phosphodiesterase inhibitor E4021 dilates the pulmonary circulation. American journal of respiratory and critical care medicine, 1999, Volume: 160, Issue:3 Topics: Analysis of Variance; Animals; Animals, Newborn; Cyclic GMP; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Fetus; Humans; Infant, Newborn; Infusions, Intravenous; Nitric Oxide; Persistent Fetal Circulation Syndrome; Phosphodiesterase Inhibitors; Piperidines; Pregnancy; Pulmonary Artery; Pulmonary Circulation; Quinazolines; Sheep; Statistics, Nonparametric; Vasodilation	1999

Article

Year

The cGMP-specific phosphodiesterase inhibitor E4021 dilates the pulmonary circulation.

American journal of respiratory and critical care medicine, 1999, Volume: 160, Issue:3

Topics: Analysis of Variance; Animals; Animals, Newborn; Cyclic GMP; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Fetus; Humans; Infant, Newborn; Infusions, Intravenous; Nitric Oxide; Persistent Fetal Circulation Syndrome; Phosphodiesterase Inhibitors; Piperidines; Pregnancy; Pulmonary Artery; Pulmonary Circulation; Quinazolines; Sheep; Statistics, Nonparametric; Vasodilation

1999